Cargando…
Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study
INTRODUCTION: The Endotoxin Activity Assay (EAA) is a useful test to risk stratify patients with severe sepsis and assess for Gram negative infection. However, the significance of intermediate levels of EAA (0.4-0.59) at the bedside has not been well elucidated. The purpose of this study was to inte...
Autores principales: | Yaguchi, Arino, Yuzawa, Junji, Klein, David J, Takeda, Munekasu, Harada, Tomoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580633/ https://www.ncbi.nlm.nih.gov/pubmed/22607642 http://dx.doi.org/10.1186/cc11350 |
Ejemplares similares
-
Early diagnosis of sepsis due to Gram-negative infection with the Endotoxin Activity Assay
por: Kang, M, et al.
Publicado: (2014) -
From the EAA conference on the TME
por: Romero, Diana
Publicado: (2020) -
Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013) -
Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013) -
Endotoxin Activity Assay levels correlate with the microbiological results of Gram-negative organisms in septic patients
por: Tsunoda, M, et al.
Publicado: (2014)